tradingkey.logo
tradingkey.logo
Suchen

Fortrea Holdings Inc

FTRE
Zur Watchlist hinzufügen
17.886USD
+0.306+1.74%
Trading geöffnet ETKurse um 15 Minuten verzögert
1.69BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Fortrea Holdings Inc Unternehmen

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc Informationen

BörsenkürzelFTRE
Name des UnternehmensFortrea Holdings Inc
IPO-datumJun 16, 2023
CEOThakrala (Anshul)
Anzahl der mitarbeiter15500
WertpapierartOrdinary Share
GeschäftsjahresendeJun 16
Addresse8 Moore Drive
StadtDURHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl27709
Telefon18774950816
Websitehttps://www.fortrea.com/
BörsenkürzelFTRE
IPO-datumJun 16, 2023
CEOThakrala (Anshul)

Führungskräfte von Fortrea Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
246.67K
+60.22%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
91.27K
+42.53%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
91.27K
+42.53%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
84.92K
+45.71%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
68.93K
+29.84%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
246.67K
+60.22%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
91.27K
+42.53%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
91.27K
+42.53%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
84.92K
+45.71%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
68.93K
+29.84%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Fortrea Holdings Inc?

Die fünf größten Anteilseigner von Fortrea Holdings Inc sind: Mr. Peter M. Neupert

Wie viele Institutionen halten Anteile an Fortrea Holdings Inc (FTRE)?

Mit Stand vom 2026Q1 halten 881 Institutionen Anteile an Fortrea Holdings Inc, mit einem Gesamtmarktwert von etwa 98.32M, was 103.93% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -25178846.00 gestiegen.